The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Combination of transcatheter arterial chemoembolization and CT-guided radiofrenquency ablation in treating advanced hepatocellular carcinoma
Author(s): 
Pages: 901-904
Year: Issue:  10
Journal: CHINESE JOURNAL OF RADIOLOGY

Keyword:  肝细胞化学栓塞治疗性射频消融术评价研究;
Abstract: 目的探讨肝动脉栓塞化疗联合CT导向下的射频消融治疗中、晚期原发性肝癌的疗效.方法 85例中、晚期原发性肝癌患者按单双日法分组原则分为A、B 2组.A组:经导管肝动脉栓塞化疗组(TACE组),共43例;B组:肝动脉栓塞化疗联合CT导向下的射频消融治疗组(联合治疗组),共42例.结果 TACE组的完全坏死率、初次复发率及1年存活率分别20.93%、39.53%和79.07%;而联合治疗组分别为92.86%、9.53%和97.62%.两组间完全坏死率、初次复发率及1年生存率的差异皆有显著性意义(其相应P值分别为0.001, 0.004, 0.009).结论肝动脉栓塞化疗联合CT导向下的射频消融治疗效果明显优于单纯栓塞化疗.
Related Articles
loading...